Tan Hai-Long, Duan Sai-Li, He Qiao, Zhang Zhe-Jia, Huang Peng, Chang Shi
Department of General Surgery, Xiangya Hospital Central South University, Changsha, Hunan, 410008, P.R. China.
Clinical Research Center for Thyroid Disease In Hunan Province, Changsha, Hunan, 410008, P.R. China.
World J Surg Oncol. 2025 Mar 25;23(1):102. doi: 10.1186/s12957-025-03722-4.
Accurate preoperative evaluation for metastatic lesions is significant for PTC patients. However, the stratification systems revealed inconsistencies in the ultrasound (US) features of cervical metastatic lymph nodes (LNs). This study aimed to investigate and develop a risk stratification model based on US radiologic features for cervical metastatic lesions in PTC patients.
This study retrospectively enrolled 1806 LNs from 1665 PTC patients who underwent US-guided fine-needle aspiration biopsy for cervical LNs from January 2010 to December 2022. Univariable and multivariable logistic regression analyses determined and developed the independent risk US features and a risk stratification model for cervical metastatic LNs. The performance of the risk stratification model was assessed and validated by the Korean Society of Thyroid Radiology and the European Thyroid Association.
Among the 1806 LNs, 1411 LNs were pathologically diagnosed with malignant. Multivariate analysis indicated that the absence of fatty hilum, cystic components, round shape (SD/LD ≥ 0.5), abundant vascularity, hyperechogenicity (including hyper and hypo-echogenicity, and hyper-echogenicity), and calcifications (include microcalcification, and macrocalcification) were independent risk US features associated with malignant LNs. A risk stratification model for cervical metastatic LNs was developed based on these suspicious US features and showed well-predicted performance (C-index 0.840; 95% CI: 0.840-0.923).
Our study proposed a new risk stratification system based on US radiologic features to predict cervical metastatic lymph nodes in PTC patients. We identified several risk factors for lymph node (LN) metastasis from PTC including the absence of fatty hilum, cystic components, round shape (SD/LD ≥ 0.5), abnormal vascularity, hyper-echogenicity, hyper- and hypo-echogenicity, microcalcification, and macrocalcification. These features could serve as valuable indicators for surgeons to accurately assess the status of cervical LNs.
准确的术前转移性病变评估对甲状腺乳头状癌(PTC)患者具有重要意义。然而,分层系统显示颈部转移性淋巴结(LNs)的超声(US)特征存在不一致性。本研究旨在基于US影像学特征,研究并建立PTC患者颈部转移性病变的风险分层模型。
本研究回顾性纳入了2010年1月至2022年12月期间因颈部LNs接受US引导下细针穿刺活检的1665例PTC患者的1806个LNs。单因素和多因素逻辑回归分析确定并建立了颈部转移性LNs的独立风险US特征和风险分层模型。该风险分层模型的性能由韩国甲状腺放射学会和欧洲甲状腺协会进行评估和验证。
在1806个LNs中,1411个LNs经病理诊断为恶性。多因素分析表明,无脂肪 hilum、囊性成分、圆形(SD/LD≥0.5)、丰富血管、高回声(包括高回声和低回声以及高回声)和钙化(包括微钙化和大钙化)是与恶性LNs相关的独立风险US特征。基于这些可疑的US特征建立了颈部转移性LNs的风险分层模型,其预测性能良好(C指数0.840;95%CI:0.840 - 0.923)。
我们的研究提出了一种基于US影像学特征的新风险分层系统,以预测PTC患者颈部转移性淋巴结。我们确定了PTC发生淋巴结转移的几个风险因素,包括无脂肪hilum、囊性成分、圆形(SD/LD≥0.5)、血管异常、高回声、高回声和低回声、微钙化和大钙化。这些特征可为外科医生准确评估颈部LNs状态提供有价值的指标。